Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy

Background: Triple-negative breast cancer (TNBC) is characterized by a more aggressive biological behavior and unfavorable outcome. Circulating and histological expression of THBS2 has been demonstrated to be a novel diagnostic and prognostic biomarker in patients with various types of tumors. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yuxiang, Lin, E., Li, Yan, Chen, Xiaobin, Chen, Minyan, Huang, Jun, Guo, Wenhui, Chen, Lili, Wu, Long, Zhang, Xiang, Zhang, Wenzhe, Jin, Xuan, Zhang, Jie, Fu, Fangmeng, Wang, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673122/
https://www.ncbi.nlm.nih.gov/pubmed/36405394
http://dx.doi.org/10.3389/pore.2022.1610559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673122/
https://www.ncbi.nlm.nih.gov/pubmed/36405394
http://dx.doi.org/10.3389/pore.2022.1610559

Ejemplares similares